Effects of liraglutide on intracerebral amyloid deposition in Alzheimer's Disease.
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 13 Jun 2017 Results of effect of liraglutide in terms of cerebral metabolic rate of glucose (n=38) presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Nov 2011 Planned end date changed from 15 Dec 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.